Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus placebo with pegylated interferon and ribavirin in insulin-resistant chronic hepatitis C
2008-006225-14Phase 3Active
- Sponsor
- ANRS
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hepatitis C virus infection comparing ACTOS + pegylated interferon + ribavirin with Placebo + pegylated interferon + ribavirin (2 arms). Primary endpoint: Reduction in HOMA score to below 2 at week 16. Started Apr 2009; status: active.
02
Drugs
pioglitazone
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-006225-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006225-14.